Fig. 5From: Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarkerKaplan–Meier survival curves comparing differential survival time between the high and low RNF43 expression groups in pan-cancer. The Kaplan–Meier survival curves of (A) OS, (B) DFS, (C) DSS, and (D) PFSBack to article page